Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Baicalein is a flavonoid derived from the
Scutellaria root
. In investigations of the inhibitors of prostaglandin synthesis in C6 rat glioma cells, we found that baicalein had a potent inhibitory activity on prostaglandin synthesis induced by either histamine or A23187, a Ca(2+) ionophore. Baicalein inhibited histamine- or A23187-induced phosphorylation of p42/p44 extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK), which causes the phosphorylation of cytosolic phospholipase A(2) (PLA(2)). Baicalein also inhibited the phosphorylation of MAPK kinase-1 (
MEK
-1) induced by histamine or A23187 in the cells. To examine the site of action of baicalein,
MEK
-1 and Raf-1 were prepared by immunoprecipitation with anti-
MEK
-1 and anti-Raf-1 antibodies, respectively. Baicalein inhibited the phosphorylation of exogenous
MEK
-1 by Raf-1 under cell-free conditions, while it did not change the phosphorylation of exogenous p42 MAPK by
MEK
-1. These results imply that baicalein inhibits the ERK/MAPK cascade, acting on the phosphorylation of
MEK
-1 by Raf-1.
...
PMID:Baicalein inhibits Raf-1-mediated phosphorylation of MEK-1 in C6 rat glioma cells. 1256 9